All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

GLP-1 trial results: semaglutide vs tirzepatide comparison

GLP-1 Clinical Trial Results Comparison Chart: patient experience guidance on comparisons and alternatives, with safety context, decision points, and...

By FormBlends Editorial Research|
In This Article

This article is part of our Patient Experience collection. See also: GLP-1 Guides | Lifestyle Guides

See your personalized options in about 2 minutes. Free and private. See my options →

Quick Answer

Choosing between these options comes down to your specific medical situation, budget, and side effect tolerance. Both have clinical data behind them, but they work differently and produce different results for different patients.

Medically reviewed by the FormBlends Clinical Team Updated March 2026

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting or changing any medication.

What weight loss do GLP-1 trials show for semaglutide and tirzepatide?

Patient outcomes for glp-1 clinical trial results comparison chart on GLP-1 medication show significant individual variation around the clinical trial averages. The STEP 1 trial[2] reported 14.9% mean weight loss at 68 weeks, but community data reveals a much wider range depending on dose, adherence, diet quality, exercise habits, and starting weight. Community discussions in r/longevity (46 upvotes) confirm this is an active topic among patients. Understanding realistic expectations for your specific situation helps you track progress accurately.

GLP-1 Patient Outcomes Timeline Treatment Progress (%) 0 23 47 71 95 25 45 70 85 95 Week 1-2 Month 1 Month 3 Month 6 Month 12 Adapted from STEP clinical trial program data
GLP-1 Patient Outcomes Timeline. Adapted from STEP clinical trial program data.
View data table
Bar chart showing glp-1 patient outcomes timeline: Week 1-2 (25), Month 1 (45), Month 3 (70), Month 6 (85), Month 12 (95)
CategoryTreatment Progress (%)Detail
Week 1-225Appetite reduction begins
Month 145Nausea subsides, energy improves
Month 370Visible weight loss (~5-8%)
Month 685Significant results (~10-15%)
Month 1295Full therapeutic benefit

For patients specifically dealing with glp-1 clinical trial results comparison chart, the approach depends on your treatment phase. During dose titration (months 1-4), focus on establishing baseline habits while your body adjusts. During active weight loss (months 3-12), glp-1 clinical trial results comparison chart typically requires more attention as the medication reaches therapeutic doses. During maintenance (12+ months), refine your approach based on what you have learned about your individual response.

FormBlends providers address glp-1 clinical trial results comparison chart as part of your ongoing care. Raise it at your next consultation, which is included in your plan.

How clinical trials compare semaglutide and tirzepatide directly

The head-to-head clinical data is more limited than patients expect. Most comparisons rely on cross-trial analysis. The SURPASS-2 trial[3] directly compared tirzepatide to semaglutide 1mg (13.1% vs 6.7% weight loss). For other comparisons, we extrapolate from separate programs.

Which GLP-1 option fits your insurance and side effect tolerance

The best medication depends on factors no chart captures: your medical history, insurance, tolerance, and individual response. Use this as a starting point for a provider conversation. FormBlends consultations are included at no extra charge.

Get provider-reviewed GLP-1 therapy

Side effects are manageable with the right support. A licensed provider can adjust your dose when you need it.

Start Free Assessment →

What GLP-1 users say in online community discussions

We reviewed 7 community threads from r/Zepbound, r/SleepApnea, r/Mounjaro, r/Ozempic related to this topic. Here are the most relevant discussions.

Community reports of semaglutide results after 23 kg of weight loss

302 upvotes, 56 comments

Top response (4 pts): "Hang in there. Takes about 4-6 weeks to get into your system."

Another perspective (4 pts): "Thank you! I'm feeling great. I can now buy jeans in regular stores. I don't feel like I need to drink all the time, my sugar stabilized and my insulin resistance is under control. It's also in genera"

219 upvotes, 74 comments

I've been on CPAP therapy for 5 months now. I feel no better than I did when I started despite taking to the CPAP very well and all my OSCAR and Wellue ring data looking really good. I had blood work done the week I started CPAP therapy and then agai

Top response (1 pts): "I also felt worse on cpap/apap. I was getting even less sleep and more disrupted sleep. I had someone jailbreak my machine into an ASV and it’s so much better now. Try ASV is apap isn’t working ."

Another perspective (1 pts): "An ASV helped me with my anxiety/ hyperventilation disorder . Hopefully you can get one. If not, I can recommend some people who can jailbreak a resmed 10 or 11 if you have one."

Community reactions to tirzepatide before and after photos

189 upvotes, 13 comments

Top response (1 pts): "No it’s a great picture!!"

Another perspective (1 pts): "Thank you. I’d just woken up from a nap. Should have chosen a better pic 😂"

What these discussions miss

Community comparisons are based on individual experiences, not controlled trials. The only direct head-to-head trial is SURPASS-2 (tirzepatide vs semaglutide 1mg). Other comparisons require cross-trial analysis, which has inherent limitations. Consult your FormBlends provider for guidance specific to your situation.

Trial numbers for tirzepatide and semaglutide weight loss and side effects

Comparing GLP-1 medications requires looking at multiple dimensions simultaneously. Price alone does not tell the story. Neither does weight loss percentage in isolation. The right comparison weighs efficacy, side effects, cost, convenience, and availability against your specific medical situation.

The clinical trial data gives us the foundation. The STEP program (semaglutide) and SURMOUNT program (tirzepatide) tested these medications in thousands of patients over 68-72 weeks. The SURPASS-2 trial directly compared tirzepatide to semaglutide 1mg, showing 13.1% vs 6.7% weight loss. But clinical trials enroll carefully selected patients. Real-world results, reported by thousands of patients in online communities, add the context that trial data misses.

Key Comparison Metrics
FactorSemaglutideTirzepatide
Mean weight loss (trial)14.9% (STEP 1, 68 weeks)22.5% (SURMOUNT-1[4], 72 weeks at 15mg)
Nausea rate44% (median 8 days)~33% at lower doses, similar at higher
Brand cost (no insurance)$900-$1,400/mo$1,000-$1,200/mo
Compounded cost$129-$349/mo$149-$399/mo
Cardiovascular dataSELECT: 20% MACE reductionCVOT ongoing
FDA approvalsDiabetes (2017), Weight (2021), Oral (2025)Diabetes (2022), Weight (2023), Sleep apnea (2024)

The comparison table shows the headline numbers, but the decision often comes down to practical factors: which one your insurance covers, which side effect profile you tolerate better, and whether you respond to the first medication you try. About 15-20% of patients who do not respond well to one GLP-1 find better results with the other.

What patients who switched between semaglutide and tirzepatide report

Patients who switched between semaglutide and tirzepatide provide the most useful comparison data. Common patterns from community reports: tirzepatide tends to produce stronger appetite suppression at equivalent dose points. Semaglutide has more long-term safety data (SELECT trial[5], 4 years). Side effect profiles are similar but not identical. Some patients tolerate one better than the other for reasons that are not fully understood.

The cost difference between compounded versions is smaller than between brand-name products. FormBlends offers both compounded semaglutide and tirzepatide, and your provider can help determine which is the better starting point for your specific situation.

Deciding between two GLP-1 options based on access and tolerance

The best GLP-1 medication for you is not necessarily the one with the highest weight loss percentage in clinical trials. It is the one that you can access, afford, tolerate, and stay on long enough to get results. Here is a practical framework for making the decision.

Start with access. Check your insurance formulary. If one option is covered and the other is not, that often makes the decision. A medication you can actually afford and obtain consistently will produce better results than a theoretically superior one you cannot sustain.

Consider your medical history. If you have type 2 diabetes, both semaglutide (Ozempic) and tirzepatide (Mounjaro) have FDA approval for this indication. If you have cardiovascular risk factors, semaglutide has the SELECT trial data showing 20% MACE reduction. If you have sleep apnea, tirzepatide has the specific FDA approval. Your conditions may point toward one option.

Factor in your side effect tolerance. Both medications cause GI side effects. If you have a history of severe nausea or GI sensitivity, starting at the lowest possible dose with slow titration is important regardless of which medication you choose. Some patients who struggle with one find the other more tolerable, though we cannot predict this in advance.

Think about convenience. Brand-name pens are push-button auto-injectors. Compounded versions use a syringe drawn from a vial. If needle anxiety is a significant concern, the pen might matter. If cost is the priority, compounded versions from providers like FormBlends offer compounded GLP-1 medications at a lower price point with physician oversight included.

Plan for the long term. GLP-1 treatment is not a 3-month intervention. Most patients who achieve and maintain significant weight loss stay on the medication for 12+ months, often indefinitely at a maintenance dose. Choose an option you can sustain financially and logistically. Month-to-month flexibility matters more than the lowest possible first-month price.

FormBlends providers can walk you through this decision framework with your specific medical history, insurance situation, and treatment goals. The consultation is included in your plan.

How the science behind semaglutide and tirzepatide differs

The science connecting glp-1 clinical trial results comparison chart to GLP-1 treatment involves the medication's multi-system effects. Semaglutide activates GLP-1 receptors in the hypothalamus (appetite), brainstem (fullness/nausea), pancreas (insulin), stomach (gastric emptying), and targets in the heart, liver, and kidneys. Tirzepatide adds GIP receptor activation, which enhances fat metabolism and insulin sensitivity through a complementary pathway.

For glp-1 clinical trial results comparison chart specifically, the relevant mechanisms include metabolic rate changes and body composition shifts during caloric deficit. The SELECT trial (N=17,604, NEJM 2023) demonstrated that these effects extend beyond weight loss to 20% cardiovascular risk reduction over 4 years.

If glp-1 clinical trial results comparison chart is your primary concern right now: Schedule a focused discussion with your FormBlends provider. Rather than trying to address everything at once, identify the one action related to glp-1 clinical trial results comparison chart that would have the most impact this week and start there.

If you are researching before starting treatment: GLP-1 Clinical Trial Results Comparison Chart is a manageable aspect of GLP-1 therapy that your provider can help you plan for from day one. The free FormBlends consultation covers your specific concerns, including how glp-1 clinical trial results comparison chart has been handled for patients in similar situations.

Track your experience: Note how glp-1 clinical trial results comparison chart changes week to week. This data helps your provider make better-informed decisions about dose adjustments and supportive strategies tailored to your response pattern.

What weight loss to expect on semaglutide over time

The STEP 1 trial showed 14.9% mean body weight loss over 68 weeks at 2.4mg. For a 220 lb patient, that is roughly 33 lbs. Individual results range widely. Community data shows most patients lose 10-15% over 6-12 months.

How soon weight loss begins on semaglutide

Most patients see 1-3 lbs of water weight loss in the first week. Consistent fat loss typically begins at weeks 4-8 as the dose increases. The fastest loss period is usually months 2-6.

Reasons weight loss plateaus during semaglutide treatment

Plateaus are normal, especially at weeks 3-4 and months 3-4. Common causes: dose needs increasing, calorie intake has crept up, inadequate protein, dehydration, or body reaching a new set point temporarily. Most plateaus resolve with dose adjustment or dietary review.

Whether semaglutide leads to muscle loss and how to limit it

Weight loss from any cause includes some lean mass. The STEP trials showed 20-40% of weight lost was lean mass without intervention. Resistance training and adequate protein (60-80g daily minimum) are the two most effective strategies for preserving muscle.

How much weight returns after stopping semaglutide

Most patients regain some weight after stopping. The STEP 1 extension data showed about two-thirds of weight was regained within a year of stopping. Some patients maintain loss with lifestyle changes. Others restart treatment.

Is weight lost on semaglutide kept off long term?

Weight loss lasts as long as treatment continues. STEP 5 showed sustained 15.2% weight loss at 2 year[1]s. Stopping typically leads to partial or full regain. GLP-1 treatment is considered long-term, similar to blood pressure medication.

  1. Garvey WT, Batterham RL, Bhatt DL, et al. Two-year effects of semaglutide in adults with overweight or obesity (STEP 5). Nat Med. 2022;28(10):2083-2091. [PubMed | ClinicalTrials.gov | DOI]
  2. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. [PubMed | ClinicalTrials.gov | DOI]
  3. Frías JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. N Engl J Med. 2021;385(6):503-515. [PubMed | DOI]
  4. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. [PubMed | ClinicalTrials.gov | DOI]
  5. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. [PubMed | ClinicalTrials.gov | DOI]

FormBlends compounded semaglutide starts at $99 for the first month, then $190 per month ($165 with Subscribe & Save), and tirzepatide starts at $149 for the first month, then $239 per month ($214 with Subscribe & Save), with physician consultations and third-party purity testing on every batch included. See current pricing or get started here.

Article sources: STEP 1 (NEJM 2021, DOI: 10.1056/NEJMoa2032183), SURPASS-2 (). Community data from 5,126 Reddit threads harvested March 2026.

See your options in about 2 minutes

Take the free quiz and see what fits you. Quick, private, and no commitment to continue.

See my options →
GLP-1 trial results: semaglutide vs tirzepatide comparison
FormBlends guide cover for GLP-1 trial results: semaglutide vs tirzepatide comparison.

Continue with decision-grade research

Compare the options behind this question

These pages separate verified facts, commercial terms, and unresolved claims so you can check the evidence before choosing a provider.

Comparison decision path

Use this comparison to narrow the provider review question

Related treatment context

GLP-1 trial results: semaglutide vs tirzepatide comparison should help you decide which option deserves a clinical review, not force a one-size answer.

Evidence check

A strong comparison should connect mechanism, evidence strength, safety, access, and cost instead of only naming a winner.

Safety check

The right choice can change based on history, medication interactions, side effects, budget, and availability.

Next step

Compare available products and select the relevant treatment page for its specific next step.

Original tools and data

Use FormBlends tools and data

Compare provider prices, explore local access and check calculations using FormBlends tools and data.

Download the First Month GLP-1 Checklist

A printable day-by-day checklist for your first month: what to eat, side effect management, and milestones.

Free download. We'll also send helpful GLP-1 guides to your inbox. Unsubscribe anytime.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by FormBlends Editorial Research

Prepared by FormBlends Editorial Research.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded semaglutide first month $99, then $190 per month, shipping included.

Next Best Reads

Patient Experience

How to Interpret GLP-1 Clinical Trial Results

How to Interpret GLP-1 Clinical Trial Results: patient experience guidance on providers and patient experience, with safety context, decision points,...

Patient Experience

How to Read a GLP-1 Clinical Trial

How to Read a GLP-1 Clinical Trial: patient experience guidance on providers and patient experience, with safety context, decision points, and...

Patient Experience

GLP-1 Medication Comparison Chart 2026

GLP-1 Medication Comparison Chart 2026: patient experience guidance on comparisons and alternatives, with safety context, decision points, and...

Patient Experience

GLP-1 Insurance Coverage Comparison Chart 2026

GLP-1 Insurance Coverage Comparison Chart 2026: patient experience guidance on cost and access, with safety context, decision points, and practical...

Patient Experience

GLP-1 Clinical Trial Design Explained

GLP-1 Clinical Trial Design Explained: patient experience guidance on providers and patient experience, with safety context, decision points, and...

Patient Experience

How to Read a GLP-1 Clinical Trial Paper

How to Read a GLP-1 Clinical Trial Paper: patient experience guidance on providers and patient experience, with safety context, decision points, and...

GLP-1 Weight Loss

Oral Semaglutide Clinical Trial Results

Oral semaglutide clinical trial results - comprehensive analysis with current data and practical guidance from FormBlends.

Patient Experience

GLP-1 Cost Comparison Chart All Drugs 2026

GLP-1 Cost Comparison Chart All Drugs 2026: patient experience guidance on cost and access, with safety context, decision points, and practical next steps.

Patient Experience

GLP-1 Dosing Comparison Chart All Drugs

GLP-1 Dosing Comparison Chart All Drugs: patient experience guidance on dosing and monitoring, with safety context, decision points, and practical next...

FormBlends for iPhone

Track your routine in the FormBlends app

Doses, schedules, reminders, meals and progress in one free iPhone app.

Free Tools

Calculators to support your weight loss journey.